Open AccessFructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death
Author(s) -
Elizabeth Selvin,
Andreea M. Rawlings,
Pamela L. Lutsey,
Nisa M. Maruthur,
James S. Pankow,
Michael W. Steffes,
Josef Coresh
Publication year - 2015
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.115.015415
Subject(s) - medicine , fructosamine , diabetes mellitus , albumin , cardiology , intensive care medicine , endocrinology
Hemoglobin A1c (HbA1c) is the standard measure to monitor glucose control in diabetes mellitus and is a marker of future cardiovascular risk. Fructosamine and glycated albumin are markers of short-term glycemic control, but their associations with cardiovascular outcomes are uncharacterized.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom